Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07605247 | Tirzepatide in the Treatment of Endometrial Cancer(TREAT-EC) | not yet recruiting | Phase 2 | 30 | Rutgers, The State University of New JerseyOTHER | 0 | May 22, 2026 | clinicaltrials |
| NCT07583329 | Comparison of Sentinel Lymph Node Applications in Endometrial Cancer Cases Performed With Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) and Conventional Laparoscopy(V-COSMOS) | not yet recruiting | — | 160 | Cukurova University |
| 1 |
| May 20, 2026 |
| clinicaltrials |
| NCT07598032 | Comparative Analysis of Immunological Responses to Vitamin D Replacement Therapy in Black and West African Men Diagnosed With Prostate Cancer: Elucidating Differential Effects on Immune Function Between Patients With Localized Disease and Those With Metastatic Progression(iCCaRE) | not yet recruiting | Phase 3 | 200 | University of Ilorin Teaching HospitalOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT06298838 | High-resolution Intra-operative PSMA PET-CT in Prostate Cancer | not yet recruiting | — | 10 | IRCCS San RaffaeleOTHER | 0 | May 18, 2026 | clinicaltrials |
| NCT07591623 | OCRA Distress & Unmet Needs | not yet recruiting | N/A | 250 | M.D. Anderson Cancer CenterOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07591831 | Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian Cancer | not yet recruiting | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | May 18, 2026 | clinicaltrials |
| NCT07592910 | A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy(MOMENT) | not yet recruiting | Phase 2 | 60 | Prostate Cancer Clinical Trials ConsortiumOTHER | 0 | May 18, 2026 | clinicaltrials |
| NCT07593066 | PRIORITY Study in Cervical Cancer(PRIORITY) | not yet recruiting | — | 700 | Pontificia Universidad Catolica de ChileOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07593339 | Sentinel Lymph Node Mapping in Early-Stage Epithelial Ovarian Cancer Surgery | not yet recruiting | N/A | 30 | Başakşehir Çam & Sakura City HospitalOTHER_GOV | 0 | May 18, 2026 | clinicaltrials |
| NCT07593833 | Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection | not yet recruiting | — | 1,000 | Tongji HospitalOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07564102 | dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy | not yet recruiting | Phase 1 / Phase 2 | 30 | Mochida Medical USA, Inc.INDUSTRY | 1 | May 15, 2026 | clinicaltrials |
| NCT07591467 | Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer(CaBRA) | not yet recruiting | Phase 3 | 330 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07586449 | A Prospective Observational Study of Senaparib in the Treatment of Epithelial Ovarian Cancer(RESO) | not yet recruiting | — | 500 | Zhejiang Cancer HospitalOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT07580651 | Quality and Safety of Real-Time Brachytherapy Treatments: Clinical Implementation of a Multipoint Scintillation Detector for Treatment Monitoring((CurieInVivo)) | not yet recruiting | N/A | 20 | CISSS de Chaudière-AppalachesOTHER_GOV | 0 | May 12, 2026 | clinicaltrials |
| NCT07581288 | Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression(MIRA) | not yet recruiting | — | 50 | University of British ColumbiaOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT07577895 | Pain Comparison: Transrectal vs. Transperineal Prostate Biopsy(TRAP-PAIN) | not yet recruiting | — | 200 | Kayseri Education and Research HospitalOTHER_GOV | 1 | May 11, 2026 | clinicaltrials |
| NCT07576842 | Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV | not yet recruiting | N/A | 750 | University of California, San DiegoOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT07568756 | Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Evaluation | not yet recruiting | Phase 2 | 60 | University of California, IrvineOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT07571499 | Helping Young People With Testicular Cancer Using Virtual and Extended Reality(TRANSCEND-XR) | not yet recruiting | N/A | 245 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 0 | May 6, 2026 | clinicaltrials |
| NCT07568236 | A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT) | not yet recruiting | Phase 2 | 54 | Chinese University of Hong KongOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT07560215 | PROMET-BR - Molecular Profiling of Metastatic Prostate Cancer: a Brazilian Cohort(PROMET-BR) | not yet recruiting | — | 100 | AstraZenecaINDUSTRY | 1 | May 1, 2026 | clinicaltrials |
| NCT07040501 | Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI | not yet recruiting | N/A | 50 | Case Comprehensive Cancer CenterOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT07555600 | Enumeration and Functional Analysis of Circulating Tumor Cells for Homologous Recombination: a Prospective Single-center Study on Advanced/Metastatic Solid Tumors(E-FACTOR) | not yet recruiting | N/A | 300 | Centre Leon BerardOTHER | 0 | Apr 29, 2026 | clinicaltrials |
| NCT07542704 | A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies | not yet recruiting | Phase 1 | 48 | Kumquat Biosciences Inc.INDUSTRY | 0 | Apr 21, 2026 | clinicaltrials |
| NCT07264088 | Identifying the Best Follow up Approach for People Who Have Had Treatment to Cure Newly Diagnosed Prostate Cancer(FOLLOW-UP) | not yet recruiting | — | 100,000 | Imperial College LondonOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT07475533 | Low-flow Versus Minimal-flow Sevoflurane Anesthesia During Robot-assisted Laparoscopic Radical Prostatectomy | not yet recruiting | N/A | 70 | Ankara City Hospital BilkentOTHER | 0 | Apr 15, 2026 | clinicaltrials |
| NCT07532148 | Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | not yet recruiting | Phase 1 | 24 | Chong Kun Dang PharmaceuticalINDUSTRY | 0 | Apr 15, 2026 | clinicaltrials |
| NCT07529418 | The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study(BALANCE) | not yet recruiting | — | 800 | Institute of Cancer Research, United KingdomOTHER | 0 | Apr 14, 2026 | clinicaltrials |
| NCT07522697 | Inavolisib for PIK3CA Mutated Advanced Endometrial Cancer: MITO END-4(MITO END-4) | not yet recruiting | Phase 2 | 48 | National Cancer Institute, NaplesOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT07523152 | Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal Study(SAPPHIRE) | not yet recruiting | N/A | 42 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 0 | Apr 13, 2026 | clinicaltrials |
| NCT07189702 | Plant-Based Nutrition for Breast or Endometrial Cancer(BEND-MBEC) | not yet recruiting | N/A | 60 | University of RochesterOTHER | 0 | Apr 8, 2026 | clinicaltrials |
| NCT07516704 | Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical Study | not yet recruiting | Early Phase 1 | 94 | Zhongda HospitalOTHER | 0 | Apr 8, 2026 | clinicaltrials |
| NCT07516808 | PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy | not yet recruiting | N/A | 20 | Beth Israel Deaconess Medical CenterOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT07492381 | A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate Cancer | not yet recruiting | N/A | 50 | ALPFA MedicalINDUSTRY | 0 | Apr 7, 2026 | clinicaltrials |
| NCT07514325 | MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer(MASTEC) | not yet recruiting | N/A | 61 | Radboud University Medical CenterOTHER | 0 | Apr 7, 2026 | clinicaltrials |
| NCT07516210 | Adaptive Radiotherapy for Safe Hypofractionation(ART-Hypo) | not yet recruiting | Phase 2 | 264 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Apr 7, 2026 | clinicaltrials |
| NCT07290998 | Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Recurrent Prostate Cancer | not yet recruiting | N/A | 12 | Alpha Tau Medical LTD.INDUSTRY | 0 | Apr 6, 2026 | clinicaltrials |
| NCT07512973 | Single-channel Fibroid Morcellation System Used in Clinical Research on Laparoscopic Myomectomy | not yet recruiting | N/A | 78 | First People's Hospital of HangzhouOTHER | 0 | Apr 6, 2026 | clinicaltrials |
| NCT07501676 | Transmucosal Uterosacral Electrical Stimulation for Pelvic Pain Relief(TUNES) | not yet recruiting | N/A | 60 | Weill Medical College of Cornell UniversityOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT07497074 | JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer | not yet recruiting | Phase 2 | 78 | Jiangsu Alphamab Biopharmaceuticals Co., LtdINDUSTRY | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07497802 | Mindfulness-Based Psychoeducation for Women With Gynecological Cancer(MIND-GYN) | not yet recruiting | N/A | 96 | Ondokuz Mayıs UniversityOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT06476639 | A Phase III Randomised Clinical Trial of Ultrasound Groin Monitoring Versus Groin Lymph Node Dissection to De-Escalate the Extent of Surgery in Vulvar Cancer(ANVU) | not yet recruiting | Phase 3 | 640 | Queensland Centre for Gynaecological CancerOTHER_GOV | 1 | Mar 24, 2026 | clinicaltrials |
| NCT07489300 | Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal Cancer(BACON) | not yet recruiting | Phase 2 | 40 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Mar 24, 2026 | clinicaltrials |
| NCT07484269 | PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan(PULSE) | not yet recruiting | — | 753 | Novartis PharmaceuticalsINDUSTRY | 0 | Mar 20, 2026 | clinicaltrials |
| NCT07485881 | 18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients | not yet recruiting | — | 59 | Assiut UniversityOTHER | 0 | Mar 20, 2026 | clinicaltrials |
| NCT07483905 | Interest in Nighttime Day Hospital Chemotherapy Infusions Among Gynecologic Cancer Patients(CHeMoON) | not yet recruiting | — | 200 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT07145437 | Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prostate Cancer (PROSTERA)(PROSTERA) | not yet recruiting | N/A | 220 | Clinique Sainte ClotildeOTHER | 0 | Mar 18, 2026 | clinicaltrials |
| NCT07480044 | A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery | not yet recruiting | N/A | 220 | Zhejiang UniversityOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT07476677 | Darolutamide ± ADT as Neoadjuvant Therapy in High-Risk/Very High-Risk Localized Prostate Cancer(ANDARP) | not yet recruiting | Phase 2 | 60 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT05479045 | A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients | not yet recruiting | Phase 2 | 24 | Georgetown UniversityOTHER | 1 | Mar 16, 2026 | clinicaltrials |
Data updated 23 days agoSource updated May 22, 2026source: clinicaltrials